Naloxone hydrochloride; oxycodone hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for naloxone hydrochloride; oxycodone hydrochloride and what is the scope of patent protection?
Naloxone hydrochloride; oxycodone hydrochloride
is the generic ingredient in one branded drug marketed by Purdue Pharma Lp and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Naloxone hydrochloride; oxycodone hydrochloride has one hundred and fifty-one patent family members in forty-one countries.
Summary for naloxone hydrochloride; oxycodone hydrochloride
International Patents: | 151 |
US Patents: | 2 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 51 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for naloxone hydrochloride; oxycodone hydrochloride |
DailyMed Link: | naloxone hydrochloride; oxycodone hydrochloride at DailyMed |
Recent Clinical Trials for naloxone hydrochloride; oxycodone hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Murdoch Childrens Research Institute | Phase 4 |
Ensysce Biosciences | Phase 1 |
Dr. Vince Clinical Research | Phase 1 |
See all naloxone hydrochloride; oxycodone hydrochloride clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for naloxone hydrochloride; oxycodone hydrochloride
US Patents and Regulatory Information for naloxone hydrochloride; oxycodone hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for naloxone hydrochloride; oxycodone hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | ⤷ Try for Free | ⤷ Try for Free |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | ⤷ Try for Free | ⤷ Try for Free |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | ⤷ Try for Free | ⤷ Try for Free |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | ⤷ Try for Free | ⤷ Try for Free |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | ⤷ Try for Free | ⤷ Try for Free |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | ⤷ Try for Free | ⤷ Try for Free |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for naloxone hydrochloride; oxycodone hydrochloride
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2913355 | PROCEDE DE PREPARATION DE CHLORHYDRATE D'OXYCODONE COMPORTANT MOINS DE 25 PPM DE 14-HYDROXYCODEINONE (PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE) | ⤷ Try for Free |
China | 101812065 | Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone | ⤷ Try for Free |
Croatia | P20180407 | ⤷ Try for Free | |
Argentina | 124161 | CLORHIDRATO DE OXICODONA QUE TIENE 14-HIDROXICODEINONA CON NIVEL INFERIOR A 100 PPM Y FORMA FARMACÉUTICA DE DOSIFICACIÓN QUE LO CONTIENE | ⤷ Try for Free |
Taiwan | I365880 | ⤷ Try for Free | |
Croatia | P20150358 | ⤷ Try for Free | |
South Korea | 20120046309 | PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE | ⤷ Try for Free |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for naloxone hydrochloride; oxycodone hydrochloride
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Try for Free | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for Naloxone Hydrochloride and Oxycodone Hydrochloride
More… ↓